4 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow SBI-087: new trials by email Literature Review of SBI-087 trials Research Report on SBI-087
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis SBI-087, Placebo - Active Rheumatoid Arthritis | Phase 2 | Completed | Pfizer | 210 | 2009-12-01 | 2013-12-03 |
| Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus SBI-087 - Lupus Erythematosus, Systemic | Phase 1 | Completed | Pfizer | 30 | 2009-03-01 | 2018-12-07 |
| Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis SBI-087 - Arthritis, Rheumatoid | Phase 1 | Completed | Pfizer | 20 | 2008-12-01 | 2024-08-14 |
| Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis SBI-087 - Rheumatoid Arthritis | Phase 1 | Completed | Pfizer | 60 | 2008-03-31 | 2023-09-13 |
Arthritis, Rheumatoid (3) · Lupus Erythematosus, Systemic (1)
Pfizer (4)
United States (3) · Canada (2) · Japan (2) · Argentina (1) · Chile (1) · Hungary (1) · Mexico (1) · Poland (1) · Serbia (1) · Spain (1)